In Diagnostic agent Omnipaque 350mg Infusion contains a radiopaque contrast medium indicated for radiographic examination using x-rays. It helps for better visualization of the parts where it is injected by a radiologist or a nurse and helps in diagnosing problems in the inside areas that are not visible to the naked eyes. This enables you to diagnose the underlying problem and helps to treat you better.
It is unsafe to consume alcohol with Omnipaque 350mg Infusion.
Omnipaque 350mg Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Omnipaque 350mg Infusion is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
It is not known whether Omnipaque 350mg Infusion alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Omnipaque 350mg Infusion should be used with caution in patients with kidney disease. Dose adjustment of Omnipaque 350mg Infusion may be needed. Please consult your doctor.
Omnipaque 350mg Infusion should be used with caution in patients with liver disease. Dose adjustment of Omnipaque 350mg Infusion may be needed. Please consult your doctor.
Omnipaque 350mg Infusion is given before imaging test, so it is important to take it at the time as advised by the doctor. If you miss the dose, your test results can be inaccurate.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: J B Chemicals and Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)